These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 6651947)

  • 1. [Epidemiology and control of poliomyelitis. II. Poliovirus vaccines].
    Carrada-Bravo T
    Bol Med Hosp Infant Mex; 1983 Nov; 40(11):604-12. PubMed ID: 6651947
    [No Abstract]   [Full Text] [Related]  

  • 2. Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
    Assaad F
    Dev Biol Stand; 1981; 47():275-82. PubMed ID: 6262152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Poliomyelitis: new revelations, renewed polemics and the Hungarian experiences].
    Dömök I
    Orv Hetil; 1983 Jun; 124(23):1355-67. PubMed ID: 6877813
    [No Abstract]   [Full Text] [Related]  

  • 4. Poliomyelitis vaccination benefits--versus risk.
    Assaad F
    Dev Biol Stand; 1979; 43():141-50. PubMed ID: 520666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polio endgame. Polio: The final assault?
    Roberts L
    Science; 2004 Mar; 303(5666):1960-8. PubMed ID: 15044779
    [No Abstract]   [Full Text] [Related]  

  • 6. Poliomyelitis--Israel.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Oct; 37(40):624-5. PubMed ID: 3139983
    [No Abstract]   [Full Text] [Related]  

  • 7. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for control of infectious diseases with poliomyelitis as an example.
    Evans AS
    Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 10. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-poliomyelitis campaign in Taiwan.
    Hsu ST; Lin SY
    Southeast Asian J Trop Med Public Health; 1971 Jun; 2(2):140-6. PubMed ID: 4332824
    [No Abstract]   [Full Text] [Related]  

  • 12. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 13. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advantages and disadvantages of antipoliomyelitis vaccines prepared with live and killed viruses].
    Melnick JL
    Bol Oficina Sanit Panam; 1980 Jun; 88(6):507-29. PubMed ID: 6448065
    [No Abstract]   [Full Text] [Related]  

  • 15. Change from oral poliovirus vaccine to inactivated poliovirus vaccine.
    Mele A; Jefferson T; Franco E; Salmaso S
    Lancet; 2002 Oct; 360(9340):1178. PubMed ID: 12387987
    [No Abstract]   [Full Text] [Related]  

  • 16. Advantages and disadvantages of killed and live poliomyelitis vaccines.
    Melnick JL
    Bull World Health Organ; 1978; 56(1):21-38. PubMed ID: 307445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poliomyelitis prevention.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 31(3):22-6, 31-4. PubMed ID: 6799765
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined use of live and killed vaccines to control poliomyelitis in tropical areas.
    Melnick JL
    Dev Biol Stand; 1981; 47():265-73. PubMed ID: 7227655
    [No Abstract]   [Full Text] [Related]  

  • 19. Paralytic poliomyelitis during the pre-, peri- and post-suspension periods of a polio immunization campaign.
    Lamina S; Hanif S
    Trop Doct; 2008 Jul; 38(3):173-5. PubMed ID: 18628551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliomyelitis vaccines.
    S Afr Med J; 1977 Nov; 52(22):868. PubMed ID: 607496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.